01—Abstract
Summary
Summary of the 10-K filed September 27, 1994. Cited figures are marked; the original filing is the authoritative source.
Archer-Daniels-Midland's fiscal 1994 10-K (year ended June 30, 1994) shows a company at record scale but with earnings that fell sharply from the prior year.
Net sales and other operating income rose 16% to a record $11.37 billiona from $9.81 billion, driven mainly by an 8% increase in average selling prices and a 5% rise in volume. However, net earnings declined 15% to $484 million ($1.40 per share) from $568 million ($1.58 per share in 1993, which included a $33 million net accounting-change credit). Gross profit rose only 7% to $1.14 billion, squeezed by higher corn costs from Midwest flooding, which the company said left roughly $100 million of corn costs unrecoverable from ethanol buyers, plus about $40 million of transportation and plant disruption costs.
Other income turned negative, and the effective tax rate rose to 34.4% from 28.4%, partly due to a one-time $14 millionb charge from the federal tax rate increase. The balance sheet remains conservative. Working capital was $2.8 billion, with cash and marketable securities of about $1.3 billion, and the current ratio was 3.5.
Long-term debt was roughly $2.0 billionc, about 27% of total capital, and shareholders' equity grew to $5.0 billion, or $14.68 per share. Management highlighted its AA- and Aa2 ratings and access to capital markets. Capital spending was substantial at $514 million in purchases of property, plant and equipment, and the company repurchased about 15.6 million shares for $355 million, a sharp step up from prior years, which signals management's view that the stock was attractively valued.
For investors, the key takeaways are strong top-line growth and a dominant position in oilseeds, corn and wheat processing, offset by weaker margins and earnings in fiscal 1994. The company is concentrated in one business segment, with roughly 50%d of sales from oilseed products, and export sales were about 12% of revenue.
Its bioproducts expansion, including amino acids, vitamins and citric acid, is a growing area. Legal and environmental matters, including Superfund PRP involvement and an Illinois EPA enforcement action, were described by management as not material.
02—Key points
Key Highlights
- Record net sales and other operating income of $11.37 billion, up 16% from $9.81 billion, driven by an 8% rise in average selling prices and a 5% increase in volume
- Net earnings fell 15% to $484 million ($1.40 per share) from $568 million ($1.58 per share), with the prior year benefiting from a $33 million net accounting-change credit
- Gross profit rose only 7% to $1.14 billion, as Midwest flooding raised corn costs (about $100 million not passed through to ethanol buyers) and cut margins in ethanol
- Effective tax rate increased to 34.4% from 28.4%, reflecting a $14 million non-recurring charge from the federal tax rate increase and a prior-year $30 million IRS settlement credit
- Strong liquidity with working capital of $2.8 billion and cash plus marketable securities of about $1.3 billion; long-term debt of $2.0 billion equals roughly 27% of total capital
- Shareholders' equity rose to $5.0 billion ($14.68 per share), and the company repurchased about 15.6 million shares for $355 million during the year
- Capital spending of $514 million and a diversified commodity footprint (oilseeds 50% of sales, corn 26%, wheat and milled products 13%) with about 16,000 employees
03—Questions
Frequently Asked Questions
Why did ADM's net earnings decline in fiscal 1994 even though sales hit a record?
Sales grew 16% on higher selling prices and volume, but gross profit grew only 7%. Midwest flooding caused a small corn crop, pushing up raw material costs. Management estimated about $100 million of higher corn costs could not be passed on to ethanol buyers, and about $40 million of costs came from transportation and plant interruptions. Higher interest expense, a lower gain on securities, and a higher effective tax rate also reduced earnings, which fell to $1.40 per share from $1.58.
How strong is ADM's balance sheet and liquidity position?
The balance sheet is conservative. Working capital was $2.8 billion with a current ratio of 3.5, and cash plus marketable securities totaled about $1.3 billion, mostly U.S. government obligations. Long-term debt of $2.0 billion represented about 27% of total capital. Standard & Poor's rated the commercial paper highest and long-term debt AA-, and Moody's rated long-term debt Aa2. The company also had $361 million in short-term bank credit lines.
How concentrated is ADM's business, and where does its revenue come from?
ADM operates in one business segment: procuring, transporting, storing, processing and merchandising agricultural commodities. Revenue in fiscal 1994 was 50% oilseed products, 26% corn products, 13% wheat and other milled products, and 11% other products and services. Export sales were about 12% of net sales, and foreign operations contributed about $3.0 billion of the $11.4 billion in sales. The company says no single customer is material.
What are the main risks to ADM's earnings that investors should watch?
The main risk is the volatility of agricultural commodity prices, which depend on weather, government farm policy, and global demand. ADM hedges to limit price risk but cannot eliminate it, as the 1994 flooding showed. Competition is intense, with major rivals including Cargill, ConAgra, CPC International, and Tate & Lyle. Environmental and legal matters, including about 20 Superfund PRP proceedings and an Illinois EPA enforcement action, were described by management as not material, though future cleanup costs cannot be reasonably estimated.
What is ADM doing to grow beyond its traditional commodity processing business?
ADM is expanding its bioproducts business. It produces feed-grade amino acids (lysine and threonine), with tryptophan expected in the coming year. It has entered the vitamin market with riboflavin and biotin and is expanding production of vitamins C and E. It also makes citric acid, MSG, and lactic acid by fermentation, and plans to start xanthan gum production. Capital spending in fiscal 1994 was $514 million, including bioproduct facilities at Decatur, Illinois, and Southport, North Carolina.
04—Continue